Announce Date | 04/23/2025 |
EPS Normalized Actual | $0.17 (Miss by $-0.19) |
EPS GAAP Actual | $0.17 (Miss by $-0.19) |
Revenue Actual | $1.35191B |
Revenue Surprise | Beat by $1351.91M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.31 | 8.44 | 5.07535 | 5.56572 | 2 |
Dec 2025 | 5.07755 | 8.83 | 4.04 | 5.83 | 8 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.17 | 0.17 | 1.35191B | -9.17% | 1351.91M |
FQ4 2024 (Dec 2024) | 0.53 | 0.53 | 1.38237B | -6.55% | 1382.37M |
FQ3 2024 (Sep 2024) | 0.64 | 0.64 | 1.465B | -6.74% | 1465M |
FQ2 2024 (Jun 2024) | 0.66 | 0.66 | 1.47252B | -11.34% | 1472.52M |
FQ1 2024 (Mar 2024) | 0.61 | 0.61 | 1.47594B | -16.29% | 1475.94M |
FQ4 2023 (Dec 2023) | 0.84 | 0.84 | 1.47289B | -17.25% | 1472.89M |
FQ3 2023 (Sep 2023) | 0.91 | 0.91 | 1.56381B | 48.63% | 1563.81M |
FQ2 2023 (Jun 2023) | 1 | 1 | 1.63948B | 46.23% | 1639.48M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.27646 | -- | 1.26029 | 1.30187 | 2 |
FQ3 2027 (Sep 2027) | 1.24467 | -- | 1.2289 | 1.26944 | 2 |
FQ2 2027 (Jun 2027) | 0.99988 | -- | 0.98721 | 1.01978 | 2 |
FQ1 2027 (Mar 2027) | 0.829 | -- | 0.8185 | 0.8455 | 2 |
FQ4 2026 (Oct 2026) | 1.35489 | -- | 1.29831 | 1.45011 | 3 |
FQ3 2026 (Jul 2026) | 1.27795 | -- | 1.22458 | 1.36776 | 5 |
FQ2 2026 (Jun 2026) | 1.27801 | -- | 1.24422 | 1.33226 | 5 |
FQ1 2026 (Mar 2026) | 1.15141 | 85.24 | 1.12097 | 1.20029 | 3 |
FQ4 2025 (Oct 2025) | 1.079 | 50.88 | 1.03394 | 1.15483 | 4 |
FQ3 2025 (Jul 2025) | 0.94453 | 32.24 | 0.90509 | 1.01091 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.61B | -- | 1.6B | 1.64B | 4 |
FQ3 2027 (Sep 2027) | 1.69B | -- | 1.67B | 1.72B | 4 |
FQ2 2027 (Jun 2027) | 1.63B | -- | 1.62B | 1.66B | 4 |
FQ1 2027 (Mar 2027) | 1.59B | -- | 1.57B | 1.61B | 4 |
FQ4 2026 (Oct 2026) | 1.73B | -- | 1.68B | 1.83B | 4 |
FQ3 2026 (Jul 2026) | 1.72B | -- | 1.67B | 1.82B | 5 |
FQ2 2026 (Jun 2026) | 1.73B | -- | 1.69B | 1.78B | 5 |
FQ1 2026 (Mar 2026) | 1.72B | 21.24 | 1.68B | 1.77B | 6 |
FQ4 2025 (Oct 2025) | 1.63B | 15.07 | 1.58B | 1.72B | 2 |
FQ3 2025 (Jul 2025) | 1.6B | 8.3 | 1.55B | 1.68B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.17 | 0.17 | 100% | |
FQ4 2024 (Dec 2024) | 0.53 | 0.53 | 100% | |
FQ3 2024 (Sep 2024) | 0.64 | 0.64 | 100% | |
FQ2 2024 (Jun 2024) | 0.66 | 0.66 | 100% | |
FQ1 2024 (Mar 2024) | 0.61 | 0.61 | 100% | |
FQ4 2023 (Dec 2023) | 0.84 | 0.84 | 100% | |
FQ3 2023 (Sep 2023) | 0.91 | 0.91 | 100% | |
FQ2 2023 (Jun 2023) | 1 | 1 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.35B | $1351.91M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.38B | $1382.37M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.47B | $1465M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.47B | $1472.52M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.48B | $1475.94M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.47B | $1472.89M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.56B | $1563.81M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.64B | $1639.48M | 100% |